ADVERTISEMENT

'Buy' Medanta Shares Maintains Motilal Oswal; Target Of Rs 1,590

<div class="paragraphs"><p>Medanta continues to demonstrate clinical leadership, achieving key milestones.</p><p>(Photo Source: Company website).</p></div>
Medanta continues to demonstrate clinical leadership, achieving key milestones.

(Photo Source: Company website).

Over the years, Medanta has developed strong capabilities in managing complex and high-risk cases, reflected in a well-diversified revenue mix.  In FY25, the top five specialties, cardiac/oncology/ gastro/ neuro/renal collectively, contributed over 66% of healthcare services revenue.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit